TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

C. Sun, A. Dobi*, A. Mohamed, H. Li, R. L. Thangapazham, B. Furusato, S. Shaheduzzaman, S. H. Tan, G. Vaidyanathan, E. Whitman, D. J. Hawksworth, Y. Chen, M. Nau, V. Patel, M. Vahey, J. S. Gutkind, T. Sreenath, G. Petrovics, I. A. Sesterhenn, D. G. McLeodS. Srivastava

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

211 Scopus citations

Fingerprint

Dive into the research topics of 'TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation'. Together they form a unique fingerprint.

Medicine & Life Sciences